EUVIMEDEUVIMED entdecken
Crossref

Assessment of additional radiation exposure during low-dose-rate brachytherapy for prostate cancer performed under computed tomography guidance

Eva A. Kuus, Victor P. Gorelov, Viacheslav S. Dekan, Aleksandr S. Grichshenkov, Olga L. Vlasova

Medical academic journal · 30.03.2026 · 26 (1) · 72-80

DOI: 10.17816/maj679261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical academic journal, online erschienen am 30.03.2026. Verfasst von Eva A. Kuus und 4 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ultrasound guidance is the standard navigation method for low-dose-rate prostate brachytherapy; however, in certain clinical situations, computed tomography guidance is used, potentially increasing the patient’s cumulative radiation exposure. Quantitative data on the additional dose attributable to intraoperative CT series during low-dose-rate (LDR) brachytherapy are limited and poorly comparable due to variability in scanning protocols and equipment characteristics. This study aimed to quantify this dose contribution and compare it with radiation exposure from standard diagnostic and interventional procedures. AIM: To substantiate the feasibility of using computed tomography to guide implantation of radioactive microsources from the standpoint of radiation exposure during low-dose-rate brachytherapy for prostate cancer. METHODS: This retrospective hospital-based cross-sectional study was conducted at the North-West District Scientific and Clinical Center named after L.G. Sokolov (Saint Petersburg, Russia). The analysis included patients with prostate cancer who underwent CT-guided low-dose-rate brachytherapy in 2023. Comparison groups were defined by the type of pelvic examinations and interventions performed at the same institution: (1) CT-guided LDR brachytherapy, (2) diagnostic pelvic examinations (radiography; multislice CT without intravenous contrast; multislice CT with intravenous contrast), and (3) endovascular interventional procedures (iliac artery stenting; prostatic artery embolization). The primary endpoint was the cumulative effective dose per procedure from intraoperative CT scans during LDR brachytherapy, derived from CT dose reports; for comparator procedures, effective doses were taken from the corresponding dose reports. Additional analyses assessed associations between radiation exposure, the number of CT series, and patient anthropometric parameters. RESULTS: The analysis included 168 patients who underwent CT-guided LDR prostate brachytherapy for whom complete CT dose reports were available. The mean age was 65.6 years (range 41–82); the mean number of implanted I-125 seeds was 65.4 (range 42–102), and the mean number of CT series per procedure was 5.2. The mean effective dose during CT-guided LDR prostate brachytherapy was 10.40 mSv (range 4.5–18.6) per procedure and varied with the number of CT series and patient body weight. Compared with diagnostic pelvic CT, the dose during LDR brachytherapy was on average 2.1 mSv higher than non-contrast CT (n = 109) and 13.6 mSv lower than contrast-enhanced CT (n = 126). Compared with interventional therapeutic procedures, the dose during LDR brachytherapy was 2.1 mSv higher than that during iliac artery stenting (n = 44) and 1.96 mSv lower than that during prostatic artery embolization (n = 26). CONCLUSION: Radiation exposure during CT-guided LDR prostate brachytherapy exceeds that of standard non-contrast diagnostic procedures due to the need for multiple scans within a single operation. At the same time, exposure during LDR brachytherapy was lower than that during contrast-enhanced pelvic CT and prostatic artery embolization. In 80% of cases, the CT-related dose during LDR brachytherapy did not exceed 14 mSv, which is relatively low for therapeutic procedures and represents a small contribution to the overall radiation burden of radiotherapy.

Zitieren

APA

Kuus, E. A., Gorelov, V. P., Dekan, V. S., Grichshenkov, A. S., & Vlasova, O. L. (2026). Assessment of additional radiation exposure during low-dose-rate brachytherapy for prostate cancer performed under computed tomography guidance. Medical academic journal, 26(1), 72-80. https://doi.org/10.17816/maj679261

Vancouver

Kuus EA, Gorelov VP, Dekan VS, Grichshenkov AS, Vlasova OL. Assessment of additional radiation exposure during low-dose-rate brachytherapy for prostate cancer performed under computed tomography guidance. Medical academic journal. 2026;26(1):72-80. doi:10.17816/maj679261

BibTeX
@article{Kuus2026,
  author = {Kuus, Eva A. and Gorelov, Victor P. and Dekan, Viacheslav S. and Grichshenkov, Aleksandr S. and Vlasova, Olga L.},
  title = {Assessment of additional radiation exposure during low-dose-rate brachytherapy for prostate cancer performed under computed tomography guidance},
  journal = {Medical academic journal},
  year = {2026},
  volume = {26},
  number = {1},
  pages = {72--80},
  doi = {10.17816/maj679261}
}
Kostenlos starten →